• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布洛芬生产的初始盐筛选程序。

Initial salt screening procedures for manufacturing ibuprofen.

作者信息

Lee Tu, Wang Yeh Wen

机构信息

Department of Chemical and Materials Engineering, National Central University, Jhong-Li City, Taiwan, Republic of China.

出版信息

Drug Dev Ind Pharm. 2009 May;35(5):555-67. doi: 10.1080/03639040802459452.

DOI:10.1080/03639040802459452
PMID:19005918
Abstract

The aim of this paper is to design initial salt screening procedures for manufacturing ibuprofen. Salt forms of a pharmaceutical acid racemic (R,S)-(+/-)-ibuprofen and their "developable" synthetic routes were ferreted out simultaneously through the screening of seven bases of sodium hydroxide, potassium hydroxide, L-arginine, L-histidine, L-lysine, diethanolamine, and tris(hydroxymethyl)aminomethane (THAM), and the match with the use of nine organic solvents of methanol, dimethyl sulfoxide, ethanol, N, N-dimethylformamide, acetonitrile, isopropyl alcohol, 1,4-dioxane, acetone, and tetrahydrofuran mainly in the presence of water in 20 mL scintillation vials. Racemic (R,S)-(+/-)-sodium ibuprofen dihydrate, a well-known ibuprofen salt and the newly discovered racemic (R,S)-(+/-)-THAM ibuprofen, appeared as white-squared powders with a molecular weight of 327.42 g/mol, a melting point of 160.17 degrees C, and the apparent solubility product, K'(sp), of 6.0 x 10(-4) M(2) at 25 degrees C were successfully synthesized by the initial salt screening methods. The new amine salt of ibuprofen was monoclinic and had a space group of P2(1)/c and lattice parameters of a = 17.578(8) degrees, b = 10.428(4) degrees, c = 9.991(4) A, alpha = 90.00 degrees , beta = 97.17(1) degrees, gamma = 90.00 degrees, and V = 1,817.05(244) A(3). The aspect ratio of the amine salt crystals of ibuprofen of approximately 1.0 implied that the crystals had a better flowability than the sodium salt counterparts. This amine salt of ibuprofen was more stable in moist or dried atmospheres and was more hydrophobic than the sodium salt of ibuprofen. Moreover, the slow dissolution of this amine salt of ibuprofen might have made it less bitter and more suitable as a sustained release drug than the sodium salt of ibuprofen. The future work is to search for the different polymorphs of this amine salt of ibuprofen and to extend the initial salt screening working logics to the formation of co-crystals.

摘要

本文旨在设计布洛芬生产的初始盐筛选程序。通过筛选氢氧化钠、氢氧化钾、L-精氨酸、L-组氨酸、L-赖氨酸、二乙醇胺和三(羟甲基)氨基甲烷(THAM)七种碱,并在20 mL闪烁瓶中主要在水存在的情况下与甲醇、二甲基亚砜、乙醇、N,N-二甲基甲酰胺、乙腈、异丙醇、1,4-二氧六环、丙酮和四氢呋喃九种有机溶剂配合使用,同时找出了药物酸外消旋体(R,S)-(±)-布洛芬的盐形式及其“可开发”的合成路线。外消旋体(R,S)-(±)-布洛芬二水合钠,一种著名的布洛芬盐,以及新发现的外消旋体(R,S)-(±)-THAM布洛芬,呈现为白色方形粉末,分子量为327.42 g/mol,熔点为160.17℃,在25℃时的表观溶度积K'(sp)为6.0×10⁻⁴ M²,通过初始盐筛选方法成功合成。布洛芬的新胺盐为单斜晶系,空间群为P2(1)/c,晶格参数为a = 17.578(8)°,b = 10.428(4)°,c = 9.991(4) Å,α = 90.00°,β = 97.17(1)°,γ = 90.00°,V = 1,817.05(244) ų。布洛芬胺盐晶体的长径比约为1.0,这意味着该晶体的流动性比钠盐晶体更好。这种布洛芬胺盐在潮湿或干燥气氛中更稳定,并且比布洛芬钠盐更疏水。此外,这种布洛芬胺盐的缓慢溶解可能使其苦味减轻,比布洛芬钠盐更适合作为缓释药物。未来的工作是寻找这种布洛芬胺盐的不同多晶型物,并将初始盐筛选工作逻辑扩展到共晶体的形成。

相似文献

1
Initial salt screening procedures for manufacturing ibuprofen.布洛芬生产的初始盐筛选程序。
Drug Dev Ind Pharm. 2009 May;35(5):555-67. doi: 10.1080/03639040802459452.
2
Dissolution enhancement by bio-inspired mesocrystals: the study of racemic (R,S)-(+/-)-sodium ibuprofen dihydrate.受生物启发的介晶对溶出度的增强作用:外消旋(R,S)-(±)-布洛芬二水合钠的研究
Pharm Res. 2008 Jul;25(7):1563-71. doi: 10.1007/s11095-008-9554-y. Epub 2008 Feb 27.
3
Stereospecific formulation and characterization of sustained release ibuprofen microspheres.布洛芬缓释微球的立体特异性制剂及表征
J Microencapsul. 1997 Jul-Aug;14(4):409-26. doi: 10.3109/02652049709033826.
4
Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.使用泊洛沙姆407固体分散体提高布洛芬的溶出度。
Arch Pharm Res. 2008 Nov;31(11):1497-507. doi: 10.1007/s12272-001-2136-8. Epub 2008 Nov 21.
5
Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.通过包合进MCM-41介孔硅酸盐提高吡罗昔康的溶出速率。
Eur J Pharm Sci. 2007 Nov;32(3):216-22. doi: 10.1016/j.ejps.2007.07.005. Epub 2007 Aug 6.
6
Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.布洛芬 tromethamine 与环糊精的新型包合物:物理化学表征
J Pharm Biomed Anal. 2009 Oct 15;50(3):449-58. doi: 10.1016/j.jpba.2009.05.031. Epub 2009 Jun 23.
7
Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin.通过与高岭土进行固态研磨形成布洛芬的物理稳定非晶相。
Eur J Pharm Biopharm. 2008 Feb;68(2):346-51. doi: 10.1016/j.ejpb.2007.06.003. Epub 2007 Jun 12.
8
Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.
Arzneimittelforschung. 1997 Jun;47(6):750-4.
9
Preparation and characterisation of novel chlorothiazide potassium solid-state salt forms: Intermolecular self assembly suprastructures.新型氯噻嗪钾固态盐形式的制备与表征:分子间自组装超结构。
Eur J Pharm Sci. 2011 Feb 14;42(3):220-9. doi: 10.1016/j.ejps.2010.11.012. Epub 2010 Nov 27.
10
Similarity in structures of racemic and enantiomeric ibuprofen sodium dihydrates.外消旋和对映体布洛芬二水合钠的结构相似性。
Acta Crystallogr C. 2005 Sep;61(Pt 9):m435-8. doi: 10.1107/S0108270105024807. Epub 2005 Aug 31.

引用本文的文献

1
Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs.生物功能性辅料:它们在克服药物固有的不良生物药剂学特性方面的新兴作用。
Pharmaceutics. 2025 May 1;17(5):598. doi: 10.3390/pharmaceutics17050598.
2
New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.新型氨基酸丙酯布洛芬酯:从合成到在药物递送系统中的应用
RSC Adv. 2022 Dec 14;12(55):35779-35792. doi: 10.1039/d2ra05804a. eCollection 2022 Dec 12.
3
Investigating the Potential Plasticizing Effect of Di-Carboxylic Acids for the Manufacturing of Solid Oral Forms with Copovidone and Ibuprofen by Selective Laser Sintering.
通过选择性激光烧结研究二元羧酸对含共聚维酮和布洛芬的固体口服制剂制造的潜在增塑作用。
Polymers (Basel). 2021 Sep 26;13(19):3282. doi: 10.3390/polym13193282.
4
Development of Pelubiprofen Tromethamine with Improved Gastrointestinal Safety and Absorption.具有改善的胃肠道安全性和吸收性的培氯布洛芬 tromethamine 的研发。
Pharmaceutics. 2021 May 18;13(5):745. doi: 10.3390/pharmaceutics13050745.
5
Melt Amorphisation of Orlistat with Mesoporous Silica Using a Supercritical Carbon Dioxide: Effects of Pressure, Temperature, and Drug Loading Ratio and Comparison with Other Conventional Amorphisation Methods.使用超临界二氧化碳使奥利司他与介孔二氧化硅发生熔融非晶化:压力、温度和药物负载率的影响以及与其他传统非晶化方法的比较
Pharmaceutics. 2020 Apr 20;12(4):377. doi: 10.3390/pharmaceutics12040377.
6
Cocrystal of Ibuprofen⁻Nicotinamide: Solid-State Characterization and In Vivo Analgesic Activity Evaluation.布洛芬-烟酰胺共晶体:固态表征及体内镇痛活性评价
Sci Pharm. 2018 Jun 4;86(2):23. doi: 10.3390/scipharm86020023.
7
Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen.根据布洛芬三种制剂吸收差异进行的药代动力学和药效学评价。
Drug Des Devel Ther. 2017 Jan 4;11:135-141. doi: 10.2147/DDDT.S121633. eCollection 2017.